NUVECTIS PHARMA INC
NVCT·67080T108·US·Common Stock·Healthcare - Biotechnology-13D/G
NVCT (NUVECTIS PHARMA INC) is held by 50 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($18.4M), VANGUARD CAPITAL MANAGEMENT LLC ($16M), GEODE CAPITAL MANAGEMENT, LLC ($8M). Net institutional sentiment: Bullish.
50
Holders
(4 Elite)
$76.4M
Total Value
80% (50)
Consensus
40 buying - 10 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders Aug 5, 2026 · Activists Aug 6, 2026 · Congress none
ActivistSOSoleus Capital Management, L.P.5.1%Aug 6, 2026
InsiderCJCarson Michael J.Vest 30K shAug 3, 2026
InsiderMCMosseri Marlio CharlesBuy $916KJun 30, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 53
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer